Integral Diagnostics |
High $3.28 |
Low $3.15 |
Trades 1,211 |
Turnover $2,399,883 |
Volume 745,243 |
| 30 June 2023 at 4:10pm | ||||
|
Market Cap (13-Nov) $635,284,800 (313th) |
Close (30-Jun) $3.28 |
Volume (30-Jun) 745,243 |
Shortsold (6-Nov) 7,492,021 (2.00%) (166th) |
|
52w High $2.60 |
52w Low $1.68 |
P/E 16.18 |
EPS 0.06 |
Initial Director's Interest Notice - Dr Nazar Bokani
IDX released this announcement to the ASX on 26 April 2021, 10:09. The announcement is not marked as price sensitive, and is 2 page(s) in length and 108.17kb in size.
You can view all announcements from IDX and see how they appear on a price chart on the announcements page.
At the date of this announcement, IDX was 0.196% short sold according to ASIC data. It was ranked the 385th most shorted stock on the ASX. It is now ranked as the 166th most shorted stock on the ASX with 2.005% of total shares short sold as of the latest reported data (06 November 2026).
| Other Recent Announcements from IDX | |
|---|---|
| Release from Escrow | 20 June 2023, 9:25 |
| Change in substantial holding | 9 May 2023, 17:01 |
| Change of Director's Interest Notice - John Atkin | 5 April 2023, 13:07 |
| Initial Director's Interest Notice - Dr Nazar Bokani | 26 April 2021, 10:09 |
| Executive Director Appointment - Dr Nazar Bokani | 16 April 2021, 12:24 |
| Change of Director's Interest Notice - John Atkin | 7 April 2021, 9:53 |
| Appendix 2A | 6 April 2021, 13:39 |
If you were already registered, log in here.